Previous Close | 2.1100 |
Open | 2.0900 |
Bid | 2.1200 x 1400 |
Ask | 2.1500 x 800 |
Day's Range | 2.0700 - 2.1500 |
52 Week Range | 2.0700 - 7.5100 |
Volume | |
Avg. Volume | 38,671 |
Market Cap | 32.952M |
Beta (5Y Monthly) | 0.30 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3410 |
Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for CPIX
Does the May share price for Cumberland Pharmaceuticals Inc. ( NASDAQ:CPIX ) reflect what it's really worth? Today, we...
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced that the Company's product portfolio of FDA-approved brands delivered combined revenues of $11.2 million during the first quarter of 2022, - which is a 6% increase over the prior year period. Adjusted earnings for the quarter were $0.5 million, or $0.03 a share. The company ended the first quarter with $96.7 million in total assets, $55.9 million in total liabilities, and $41.0 million of sharehold
Specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a national co-promotion agreement with Verity Pharmaceuticals International Ltd. to support Cumberland's new Sancuso® oncology support product.